Essential thrombocythemia in childhood
- PMID: 9255910
- DOI: 10.1055/s-2007-996102
Essential thrombocythemia in childhood
Abstract
In addition to the criteria of the Polycythemia Vera Study Group, positive markers for essential thrombocythemia (ET) include spontaneous BFU-E, splenomegaly, and megakaryocyte morphology in bone marrow smears and biopsy material. The hematologic features of 11 reported cases of ET in childhood showed platelet counts in excess of 1000 x 10(9)/L in all, slight leukocytosis in 8, and splenomegaly in 9. The presenting thrombohemorrhagic manifestations in 8 symptomatic cases were microcirculatory disturbances and transient neurologic ischemic attacks in 2, recurrent mucocutaneous bleedings in 6, and priapism in 1. There are no reports of ET in childhood complicated by microcirculatory disturbances at platelet counts below 1000 x 10(9)/L. Anagrelide and alpha-interferon, which are non-leukemogenic agents for the reduction of platelet counts, may become the treatment of choice in childhood ET. Anagrelide is tolerated better than alpha-interferon. The potential leukemogenic drugs hydroxyurea and busulfan should be used cautiously and withheld as long as possible.
Similar articles
-
Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.Semin Thromb Hemost. 1997;23(4):339-47. doi: 10.1055/s-2007-996107. Semin Thromb Hemost. 1997. PMID: 9263350
-
Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.Platelets. 2006 Dec;17(8):528-44. doi: 10.1080/09537100600758677. Platelets. 2006. PMID: 17127481
-
Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.Semin Thromb Hemost. 2006 Apr;32(3):174-207. doi: 10.1055/s-2006-939431. Semin Thromb Hemost. 2006. PMID: 16673274 Review.
-
The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.Semin Thromb Hemost. 2006 Sep;32(6):589-604. doi: 10.1055/s-2006-949664. Semin Thromb Hemost. 2006. PMID: 16977569 Review.
-
Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.Haematologica. 2000 Nov;85(11):1126-34. Haematologica. 2000. PMID: 11064463
Cited by
-
Primary thrombocytosis in children.Haematologica. 2014 Apr;99(4):620-8. doi: 10.3324/haematol.2013.092684. Haematologica. 2014. PMID: 24688110 Free PMC article. Review.
-
Anagrelide: a review of its use in the management of essential thrombocythaemia.Drugs. 2006;66(1):111-31. doi: 10.2165/00003495-200666010-00006. Drugs. 2006. PMID: 16398570 Review.
-
Essential thrombocythemia with (type2) calreticulin presented as stuttering priapism case report and review of literature.Clin Case Rep. 2020 Nov 18;9(1):399-404. doi: 10.1002/ccr3.3541. eCollection 2021 Jan. Clin Case Rep. 2020. PMID: 33489189 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources